Caricamento...
Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
Over the last decade, several rhythm‐versus rate‐control trails in patients with atrial fibrillation (AF) have failed to demonstrate benefit of the rhythm control strategy with respect to mortality and morbidity. This had let to the guideline recommendation that antiarrhythmic drug therapy should be...
Salvato in:
| Pubblicato in: | Clin Cardiol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley Periodicals, Inc.
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652313/ https://ncbi.nlm.nih.gov/pubmed/22246949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20959 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|